Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1985 4
1986 5
1987 4
1988 4
1989 3
1990 2
1991 4
1993 5
1995 3
1996 2
1998 2
1999 5
2000 4
2001 2
2002 3
2003 5
2004 3
2005 4
2006 8
2007 7
2008 4
2009 2
2010 4
2011 4
2012 8
2013 2
2014 5
2015 7
2016 10
2017 7
2018 3
2019 8
2020 13
2021 10
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Results by year
Filters applied: . Clear all
Page 1
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P, Röth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L. Hillmen P, et al. Among authors: fu cl. N Engl J Med. 2006 Sep 21;355(12):1233-43. doi: 10.1056/NEJMoa061648. N Engl J Med. 2006. PMID: 16990386 Free article. Clinical Trial.
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, Gaya A, Coyle L, de Castro C, Fu CL, Maciejewski JP, Bessler M, Kroon HA, Rother RP, Hillmen P. Brodsky RA, et al. Among authors: fu cl. Blood. 2008 Feb 15;111(4):1840-7. doi: 10.1182/blood-2007-06-094136. Epub 2007 Nov 30. Blood. 2008. PMID: 18055865 Free article. Clinical Trial.
Growing Dural Mass That Was Not a Meningioma.
Bilani N, Oppenheimer A, Diacovo MJ, Fu CL. Bilani N, et al. Among authors: fu cl. JCO Oncol Pract. 2021 Feb;17(2):116-117. doi: 10.1200/OP.20.00348. Epub 2020 Jul 9. JCO Oncol Pract. 2021. PMID: 32644905 No abstract available.
161 results